title: Rapid changes in hepatitis C virus quasispecies produced by a single dose of IFN-alpha in chronically infected patients.
abstract: The effects of a single dose of 3 international megaunits of interferon-alpha2b (IFN-alpha2b) on hepatitis C virus (HCV) load and quasispecies were examined 24 h after administration in 12 previously untreated, chronically infected patients. All patients had viremia loads appreciably reduced relative to baseline values, thus confirming that the viral load is rapidly affected by IFN-alpha2b. Five patients also exhibited changes in plasma HCV quasispecies composition that were clearly evident by single-strand conformation polymorphism, analysis, thus indicating that one dose of IFN-alpha2b may suffice to produce rapid perturbations in the genetic heterogeneity of circulating HCV. Prior to IFN-alpha2b administration, 3 patients exhibited viral quasispecies differences between plasma and peripheral blood mononuclear cells (PBMC). Interestingly, in 2 such patients, the viral quasispecies found in the 24-h plasma resembled that in the pre-IFN PBMC. The latter finding raises the possibility that in these patients, the differences in quasispecies composition between pre-IFN and post-IFN plasma resulted from increased representation of lymphoid tissue-originated variants in the latter sample, possibly because of poor sensitivity to IFN-alpha2b of HCV replication in the lymphoid compartment.
authors: Virology Section, Department of Biomedicine and Retrovirus Center, University of Pisa, Pisa, Italy.
authors: C
authors: C
authors: Fornai
authors: F
authors: F
authors: Maggi
authors: F
authors: F
authors: Favilli
authors: M L
authors: ML
authors: Vatteroni
authors: M
authors: M
authors: Pistello
authors: S
authors: S
authors: Marchi
authors: P
authors: P
authors: Ciccorossi
authors: G
authors: G
authors: Antonelli
authors: M
authors: M
authors: Bendinelli
mesh_terms: D001483:Base Sequence; D017931:DNA Primers / Q000235:genetics; D014644:Genetic Variation; D016174:Hepacivirus / Q000187:drug effects* / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D007963:Leukocytes, Mononuclear / Q000821:virology; D010949:Plasma / Q000821:virology; D018807:Polymorphism, Single-Stranded Conformational; D012367:RNA, Viral / Q000097:blood / Q000235:genetics; D011994:Recombinant Proteins; D013045:Species Specificity; D014766:Viremia / Q000188:drug therapy / Q000821:virology
chemical_list: D017931:DNA Primers; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins